Heron Therapeutics Inc.
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It … Read more
Market Cap & Net Worth: Heron Therapeutics Inc. (0J4V)
Heron Therapeutics Inc. (LSE:0J4V) has a market capitalization of $66.39 Million ($66.39 Million) as of March 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #17696 globally and #337 in its home market, demonstrating a -10.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Heron Therapeutics Inc.'s stock price $0.85 by its total outstanding shares 78019000 (78.02 Million).
Heron Therapeutics Inc. Market Cap History: 2018 to 2026
Heron Therapeutics Inc.'s market capitalization history from 2018 to 2026. Data shows change from $2.03 Billion to $66.39 Million (-33.44% CAGR).
Heron Therapeutics Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Heron Therapeutics Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.68x
Heron Therapeutics Inc.'s market cap is 0.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $2.03 Billion | $77.47 Million | -$178.84 Million | 26.22x | N/A |
| 2019 | $1.87 Billion | $145.97 Million | -$204.75 Million | 12.83x | N/A |
| 2020 | $1.63 Billion | $88.64 Million | -$227.28 Million | 18.44x | N/A |
| 2021 | $793.61 Million | $86.35 Million | -$220.68 Million | 9.19x | N/A |
| 2022 | $198.40 Million | $107.67 Million | -$182.02 Million | 1.84x | N/A |
| 2023 | $133.41 Million | $127.04 Million | -$110.56 Million | 1.05x | N/A |
| 2024 | $117.54 Million | $144.28 Million | -$13.58 Million | 0.81x | N/A |
| 2025 | $105.13 Million | $154.90 Million | -$20.20 Million | 0.68x | N/A |
Competitor Companies of 0J4V by Market Capitalization
Companies near Heron Therapeutics Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Heron Therapeutics Inc. by market ranking:
- ACT Energy Technologies Ltd. (TO:ACX): Ranked #17687 globally with a market cap of $113.97 Million USD ( CA$163.69 Million CAD).
- Domo Inc (NASDAQ:DOMO): Ranked #17688 globally with a market cap of $113.95 Million USD.
- Senao Networks (TWO:3558): Ranked #17697 globally with a market cap of $113.80 Million USD ( NT$3.77 Billion TWD).
- Franklin Covey Company (NYSE:FC): Ranked #17698 globally with a market cap of $113.68 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #17687 | ACT Energy Technologies Ltd. | TO:ACX | $113.97 Million | CA$7.48 |
| #17688 | Domo Inc | NASDAQ:DOMO | $113.95 Million | $3.93 |
| #17697 | Senao Networks | TWO:3558 | $113.80 Million | NT$128.50 |
| #17698 | Franklin Covey Company | NYSE:FC | $113.68 Million | $12.08 |
Heron Therapeutics Inc. Historical Marketcap From 2018 to 2026
Between 2018 and today, Heron Therapeutics Inc.'s market cap moved from $2.03 Billion to $ 66.39 Million, with a yearly change of -33.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $66.39 Million | -36.85% |
| 2025 | $105.13 Million | -10.55% |
| 2024 | $117.54 Million | -11.90% |
| 2023 | $133.41 Million | -32.76% |
| 2022 | $198.40 Million | -75.00% |
| 2021 | $793.61 Million | -51.46% |
| 2020 | $1.63 Billion | -12.69% |
| 2019 | $1.87 Billion | -7.83% |
| 2018 | $2.03 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Heron Therapeutics Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $66.39 Million USD |
| MoneyControl | $66.39 Million USD |
| MarketWatch | $66.39 Million USD |
| marketcap.company | $66.39 Million USD |
| Reuters | $66.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.